PLATFORM KINETICS LIMITED

Their core work

Platform Kinetics Limited is a Leeds-based deep-tech SME specialising in magnetically actuated micro- and nano-scale systems, with particular expertise in bio-inspired locomotion at low Reynolds numbers — the physics governing how bacteria and microorganisms swim. In their first H2020 project (ABIOMATER), they contributed materials engineering and microfluidic component expertise to the design of soft metamaterials that mimic biological swimmers and can be controlled by magnetic fields. Their second project (MagElastic) applied closely related magneto-elastic physics to a commercially relevant problem: point-of-care diagnostic devices built on lab-on-a-chip technology. By that project they were also active in commercialisation strategy — lean canvas, investor access, start-up formation — suggesting the company sits at the interface between advanced physics research and early-stage product development.

What they specialise in

How they've shifted over time

In their earliest H2020 work (2015–2019), Platform Kinetics was embedded in fundamental FET research — soft condensed matter, bio-inspired magnetic materials, metamaterials, and the exotic physics of nanoscale swimming. This is blue-sky science territory, funded under the Future and Emerging Technologies pillar with no immediate product expectation. By their second project (2018–2020), the vocabulary shifted sharply: point-of-care diagnostics, commercialisation roadmap, lean canvas, and start-up formation entered the picture alongside the familiar microfluidic and lab-on-a-chip terms. The trajectory is a classic deep-tech arc — from curiosity-driven physics to applied diagnostics to market-ready product strategy — compressed into just five years of EU project activity.

Platform Kinetics appears to be moving from academic research partner toward a technology-to-market bridge role, likely developing or spinning out products in magnetically actuated microfluidic diagnostics — making them an interesting commercialisation partner for university-led consortia in health technology.

How they like to work

Platform Kinetics has participated exclusively as a consortium partner, never as coordinator, across both of their H2020 projects. Their consortia were small — six unique partners across four countries — which suggests they work best in focused, specialist teams rather than large multi-partner programmes. There is no evidence of partner repetition given the small project count, so no loyalty pattern can be established, but the FET pillar context implies they were selected for niche technical expertise rather than as a volume contributor.

Platform Kinetics has collaborated with six unique partners across four countries, a relatively contained European network consistent with their two-project history. Their collaborations sit within the FET research ecosystem, likely involving universities and research institutes alongside other deep-tech SMEs.

What sets them apart

Platform Kinetics occupies a rare position: a private SME with genuine expertise in the physics of magnetically actuated soft matter — territory usually dominated by university groups — that has also demonstrated practical commercialisation capability in the same domain. For a consortium building a health-tech or diagnostics project, they offer the unusual combination of FET-grade scientific credibility and startup-facing business development skills. Post-Brexit, their UK status introduces eligibility constraints for Horizon Europe, but for Horizon 2020 legacy work and for collaborations involving UK-funded programmes (Innovate UK, UKRI), they remain a valid and differentiated partner.

Highlights from their portfolio

• ABIOMATER
  The larger and more fundamental of the two projects (EUR 524,780), this FET-RIA grant placed Platform Kinetics inside cutting-edge research on bio-inspired magnetic metamaterials and nanobot-scale locomotion — extremely specialist territory that few private SMEs operate in.
• MagElastic
  Though modest in funding (EUR 31,531, likely a CSA), this project reveals the company's commercialisation orientation, with keywords covering lean canvas, investor access, and spin-off creation alongside the technical microfluidics work.